Skip to content
Botulinum toxin type b
NeuroBloc (botulinum toxin type b) is an unknown pharmaceutical. Botulinum toxin type b was first approved as Neurobloc on 2001-01-22. It is used to treat sialorrhea in the USA. It has been approved in Europe to treat torticollis.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
stomatognathic diseasesD009057
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
daxxifyBiologic Licensing Application2023-03-22
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
sialorrheaHP_0002307D012798K11.7
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
22 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
StrokeD020521EFO_0000712I63.911113
TorticollisD014103HP_0000473F45.8213
NeoplasmsD009369C8011
Wounds and injuriesD014947T14.811
Spinal cord injuriesD013119EFO_100191911
Brain injuriesD001930S06.911
Dystonic disordersD020821G2411
Low back painD017116HP_0003419M54.511
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SialorrheaD012798HP_0002307K11.7245
Cerebral palsyD002547G801212
Multiple sclerosisD009103EFO_0003885G35111
Traumatic brain injuriesD000070642S06111
Amyotrophic lateral sclerosisD000690EFO_0000253G12.21111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Systemic sclerodermaD012595EFO_0000717M3411
HyperhidrosisD006945HP_000097511
Abdominal herniaD046449K4611
Ventral herniaD006555EFO_1001866K4311
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hidradenitis suppurativaD017497L73.211
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBOTULINUM TOXIN TYPE B
INN
Description
Myobloc, NeuroBloc (botulinum toxin type b) is an neurotoxin pharmaceutical. Botulinum toxin type b was first approved as Myobloc on 2001-01-22. It is used to treat sialorrhea in the USA. It has been approved in Europe to treat torticollis.
Classification
Neurotoxin
Drug classfluoroquinolone derivatives, nonantibacterial indication (e.g., antineoplastic antibiotics)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL1201569
ChEBI ID
PubChem CID
DrugBankDB00083
UNII ID
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 513 documents
View more details
Safety
Black-box Warning
Black-box warning for: Daxxify
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
47,192 adverse events reported
View more details